Ophthalmology News and Research

RSS

Ophthalmology is the specialized field of medicine that focuses on the health of the eye. It includes the anatomy, physiology and diseases that may affect the eye. Historically, the science of ophthalmology encompassed all aspects of visual function, both in health and in illness. Additionally, ophthalmology also includes animal eyes as ocular function and optic diseases are similar among humans and animals.

One-day seminar to explore ophthalmic innovations

The newest ophthalmic innovations with market potential will be the focus of a one-day seminar in Seattle on May 3, 2013 that will connect scientists, venture capitalists, pharmaceutical representatives and others.

3 Nov 2012

Top-line results from Aerie Pharmaceuticals' AR-13324 Phase 2a study on glaucoma

Aerie Pharmaceuticals, a biotechnology company focused on the discovery and development of novel treatments for glaucoma, today announced positive top-line results from its Phase 2a study evaluating AR-13324 for the treatment of glaucoma.

3 Nov 2012

Inotek announces final data from trabodenoson Phase 2 trial on PAOG or ocular hypertension

Inotek Pharmaceuticals Corp., a leader in the development of innovative drug candidates to address significant diseases of the eye, today announced that final data from a Phase 2 clinical trial of trabodenoson, also known as INO-8875, in patients with primary open-angle glaucoma or ocular hypertension will be presented at the Ophthalmology Innovation Summit on Thursday, November 8, 2012 at the Chicago Marriott Downtown Magnificent Mile in Chicago, IL.

2 Nov 2012

Mass. Eye and Ear opens new outpatient surgical center in Longwood/Mission Hill area of Boston

Massachusetts Eye and Ear, along with the Beal Companies, LLP, today celebrated the grand opening of its new outpatient surgical center at 800 Huntington Avenue in the Longwood/Mission Hill area of Boston. The location will provide access to Mass. Eye and Ear's world-class physicians and surgeons, and outpatient services.

1 Nov 2012

Gas superior to air tamponade in lower quadrant vitrectomy

Gas and air are suitable tamponading agents for use during vitrectomy for rhegmatogenous retinal detachment, however air tamponade should only be used in cases that are restricted to the superior quadrants, study findings show.

30 Oct 2012

Video-article details new laser-activated bio-adhesive polymer

A new video-article in JoVE, Journal of Visualized Experiments, details the use of a new laser-activated bio-adhesive polymer. The chitosan-based polymer, SurgiLux, was developed by scientists at the University of New South Wales.

26 Oct 2012

Ophthotech announces data from Fovista Phase 2b trial on wet AMD

Ophthotech Corporation today announced that data from a large, prospective, randomized, controlled Phase 2b clinical trial of Ophthotech's Fovista anti-PDGF therapy (1.5 mg) in patients with neovascular age-related macular degeneration (wet AMD) will be presented during Retina Subspecialty Day at the American Academy of Ophthalmology Annual Meeting (AAO) on Sat., Nov. 10, 2012 at 9:15 a.m.

25 Oct 2012

Leaders come together to discuss latest advances in neurosciences

Stony Brook Medicine's Neurosciences Institute brings together leaders in the field of neurosciences to present the latest advances in research and clinical care for neurodegenerative disorders, neuropsychiatric disorders, and neuro-ophthalmology.

20 Oct 2012

Study reveals key chemical process that corrects potential visual errors in low-light conditions

On the road at night or on a tennis court at dusk, the eye can be deceived. Vision is not as sharp as in the light of day, and detecting a bicyclist on the road or a careening tennis ball can be tough.

20 Oct 2012

Clinical and demographic factors impact visual acuity in retinal vasculitis

Just over one-third of individuals with retinal vasculitis will experience vision loss despite undergoing therapy for the condition, while approximately the same proportion will experience some improvement, show study results.

19 Oct 2012

Quick, cheap eye scan can predict brain damage in people with multiple sclerosis

An inexpensive, five-minute eye scan can accurately assess the amount of brain damage in people with the debilitating autoimmune disorder multiple sclerosis (MS), and offer clues about how quickly the disease is progressing, according to results of two Johns Hopkins studies.

19 Oct 2012

Vision care providers worry about effect of reporting driving concerns

Two-thirds of vision care providers routinely enquire about their older patients’ driving, while almost half believe that reporting patients negatively to government agencies affects the physician–patient relationship, show US study results.

17 Oct 2012

Abnormal visual processing and circuitry in the brain impacts fixational saccades

Little is known about oculomotor function in amblyopia, or "lazy eye," despite the special role of eye movements in vision. A group of scientists has discovered that abnormal visual processing and circuitry in the brain have an impact on fixational saccades (FSs), involuntary eye movements that occur during fixation and are important for the maintenance of vision.

17 Oct 2012

Antibiotic injections are associated with lower risk of infection in cataract surgery

Intracameral antibiotic injections were associated with a 22-fold reduction in the risk of postoperative infection following cataract surgery when compared with the standard post-operative treatment of antibiotic eyedrops, according to a Kaiser Permanente study.

16 Oct 2012

Experts discuss recent U.S. meningitis outbreak at ANESTHESIOLOGY 2012 meeting

Four experts in anesthesiology, infectious disease and pain medicine discussed the recent U.S. meningitis outbreak in the Late-Breaking Education Panel, "The Fungal Meningitis Crisis," on Sunday, Oct. 14.

16 Oct 2012

Einstein College receives $3M grant to establish Glenn Center for the Biology of Human Aging Research

Albert Einstein College of Medicine of Yeshiva University has received a $3 million grant from the Glenn Foundation for Medical Research to establish the Paul F. Glenn Center for the Biology of Human Aging Research. The grant will fund research to translate recent laboratory and animal discoveries into therapies to slow human aging.

15 Oct 2012

Cigarette smoking may increase risk of age-related cataract

Cigarette smoking is a well-known risk factor for a wide-range of diseases. Now, scientists have evidence that smoking may also increase the risk of age-related cataract, the leading cause of blindness and vision loss in the world.

13 Oct 2012

NYSCF conference to discuss latest advances in stem cell research

Leaders in translational stem cell research from across the country and around the world will present findings on how advances in stem cell science lead to better treatments and cures to disease and injury at The New York Stem Cell Foundation's Seventh Annual Translational Stem Cell Research Conference, held at The Rockefeller University in Manhattan on October 10-11.

11 Oct 2012

Ranibizumab improves driving prospects for AMD patients

Treatment with ranibizumab can preserve and even improve the perceived driving ability of patients with age-related macular degeneration, show the results of two randomized trials.

10 Oct 2012

Heavy caffeinated coffee consumption may increase risk of exfoliation glaucoma

A new study suggests caffeinated coffee drinkers should limit their intake to reduce their chances of developing vision loss or blindness. According to a scientific paper in Investigative Ophthalmology & Visual Science, heavy caffeinated coffee consumption is associated with an increased risk of developing exfoliation glaucoma, the leading cause of secondary glaucoma worldwide.

4 Oct 2012